Tag: cancer

biotech

First precision therapy prostate cancer drug approved

biotech

Breast cancer vaccine endpoints met with 74% immune response

biotech

Pan Cancer T raises €10m for first-in-human trial of novel TCR-T cell therapy for triple-negative breast cancer

biotech

Vivacta Bio shows promising results for in vivo CAR-T therapy in non-Hodgkin’s lymphoma

biotech

CRS programme to feature Poolbeg Pharma trial

biotech

Potent and selective antitumour activity in acute myeloid leukaemia study

biotech

Oncoinvent publishes phase 1 ovarian cancer results

biotech

Lower doses of immunotherapy for skin cancer give better results